Clinical Trial Update: Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections [Phase 3]

View source ↗

Summary

Phase 3 trial comparing cotrimoxazole to vancomycin for invasive MRSA infections has completed. It evaluated outcomes in meningitis, sepsis, and pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Methicillin-resistant Staphylococcus Aureus Infection
• Pneumonia
• Sepsis

Drugs mentioned

• Cotrimoxazole (trimethoprim-sulfamethoxazole)
• Vancomycin (vancomycin)

Snippet

Sponsor: Rabin Medical Center | Conditions: Staphylococcal Infections, Meningitis | Phase 3 | Status: COMPLETED